Basic Information
Basic information for LINC00343-323-20aa-1
Peptide Name LINC00343-323-20aa-1
Genome Position chr13:105764130-105764189[+]
Species Human
Peptide Sequence MVLSCLEFVLITICIHPVPP
Peptide Length 20
Unique No (LINC00343-202-20aa-2,LINC00343-205-20aa,LINC00343-225-20aa-2,LINC00343-232-20aa,LINC00343-243-20aa-3,LINC00343-250-20aa-2,LINC00343-252-20aa-1,LINC00343-253-20aa,LINC00343-255-20aa,LINC00343-257-20aa,LINC00343-258-20aa-1,LINC00343-262-20aa,LINC00343-264-20aa-1,LINC00343-265-20aa-2,LINC00343-270-20aa-2,LINC00343-291-20aa,LINC00343-293-20aa,LINC00343-294-20aa-2,LINC00343-299-20aa-2,LINC00343-303-20aa-2,LINC00343-315-20aa,LINC00343-321-20aa-2,LINC00343-324-20aa-1,LINC00343-326-20aa-1,LINC00343-328-20aa-2)
Grand Average of Hydropathicity 1.71
Relative Molecular Mass 2567.12
Experimental Evidences no
lncRNA ID/Name ENSG00000226620;LINC00343
Transcript ID/Name ENST00000670771;LINC00343-323
Transcript Length 1983
Coding Ability 0.4937
DNA Sequence Corresponding to Peptide ATGGTTTTGTCTTGTCTTGAATTTGTTTTAATTACAATTTGTATACATCCTGTTCCACCC
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :